Finance

Beta
Lists
4005:TADAWUL
National Medical Care Company SJSC
SAR 104.00
-1.89%
(-2.00) 1D
Jun 10, 3:17:54 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4005...
Open
SAR 105.60
High
SAR 106.80
Low
SAR 103.10
Mkt. cap
4.66B
Avg. vol.
228.07K
Volume
153.06K
Dividend
2.88%
Quarterly dividend
SAR 0.75
Ex-dividend date
May 5, 2026
P/E ratio
16.28
52-wk high
SAR 183.50
52-wk low
SAR 94.90
EPS
SAR 6.39
Shares outstanding
22.62M
Open
SAR 105.60
High
SAR 106.80
Low
SAR 103.10
Mkt. cap
4.66B
Avg. vol.
228.07K
Volume
153.06K
Dividend
2.88%
Quarterly dividend
SAR 0.75
Ex-dividend date
May 5, 2026
P/E ratio
16.28
52-wk high
SAR 183.50
52-wk low
SAR 94.90
EPS
SAR 6.39
Shares outstanding
22.62M
News stories
From sources across the web
About National Medical Care Company SJSC
CEO-
Employees-
FoundedAug 2003
Headquarters-
SectorHealth care provider
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
397.87M
412.41M
404.76M
387.99M
Cost of goods sold
250.39M
260.94M
263.81M
265.34M
Cost of revenue
250.39M
260.94M
263.81M
265.34M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51.69M
50.11M
60.22M
53.54M
Operating expense
62.50M
61.07M
58.99M
59.67M
Total operating expenses
312.89M
322.01M
322.80M
325.01M
Operating income
84.98M
90.40M
81.96M
62.98M
Other non operating income
-
-
-
-
EBT including unusual items
83.19M
87.49M
80.67M
58.67M
EBT excluding unusual items
83.19M
87.49M
80.67M
58.67M
Income tax expense
3.25M
5.29M
9.71M
6.21M
Effective tax rate
3.91%
6.04%
12.03%
10.59%
Other operating expenses
-300.62K
-122.50K
-328.24K
285.65K
Net income
79.94M
82.20M
70.96M
52.46M
Net profit margin
20.09%
19.93%
17.53%
13.52%
Earnings per share
1.79
1.84
1.59
1.17
Interest and investment income
5.59M
4.12M
3.68M
4.08M
Interest expense
-7.38M
-7.03M
-4.96M
-8.39M
Net interest expenses
-1.79M
-2.92M
-1.29M
-4.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
104.18M
110.07M
107.40M
81.21M
Gain or loss from assets sale
-30.44K
-50.00K
-8.00K
317.48K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more